Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
05/2010
05/26/2010EP1572656B1 Compounds useful as pesticides
05/26/2010EP1560820B1 Novel anthranilamide insecticides
05/26/2010EP1497278B1 Heterocyclic amide derivatives as cytokine inhibitors
05/26/2010EP1303495B1 Substituted 5-alkynyl pyrimidines having neurotrophic activity
05/26/2010CN1949966B Quinoxalin-2-one derivatives, crop protection agents comprising the same and method for production and use therof
05/26/2010CN1867331B Thalidomide analogs as TNF-alpha modulators
05/26/2010CN1826115B Substituted piperidine compounds and methods of their use
05/26/2010CN1805748B 2-aminopyrimidine derivatives as RAF kinase inhibitors
05/26/2010CN1720245B Oxime ester photoinitiators with heteroaromatic groups
05/26/2010CN1713907B N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors
05/26/2010CN1711347B Use of metal complex compounds as oxidation catalysts
05/26/2010CN1656073B Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
05/26/2010CN1642920B 5-substituted-alkylaminopyrazole derivatives as pesticides
05/26/2010CN1642580B Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
05/26/2010CN1596113B Use of delta receptor agonist compound in preparing medicine for treating depression
05/26/2010CN1489580B 咪唑衍生物 Imidazole derivatives
05/26/2010CN101715446A Method for producing amide compound
05/26/2010CN101715442A Heterocyclic aspartyl protease inhibitors
05/26/2010CN101712675A Nitrogenous benzheterocycle derivate and application thereof to treating nervous and mental diseases
05/26/2010CN101712660A Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
05/26/2010CN101712657A heteroarylcarbamoylbenzene derivative
05/26/2010CN101712647A Metal complex for optical recording material and preparation method as well as prepared optical recording dye thereof
05/26/2010CN101712632A Substituted tetracycline compounds
05/25/2010US7724943 Rapid and robust 3D/3D registration technique
05/25/2010US7723527 Benzoimidazole compounds
05/25/2010US7723526 Benzoimidazole compounds
05/25/2010US7723522 Pyridine derivative production method
05/25/2010US7723494 Yellow anionic disazo dyes
05/25/2010US7723384 1H-2-Benzazepine-1,5(2H)-dione derivatives in which the N is connected via alkylene to a saturated or monounsaterated nitrogen heterocycle, e.g.,2-(3-{4-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]piperazin-1-yl}propyl)-3,4-dihydro-1H-2-benzazepine-1,5(2H)-dione; dopamine-3 receptor modulators
05/25/2010US7723374 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist
05/25/2010US7723372 Spiro[2-cyclohexene-1,3'-[3H]indole]-2',4(1'H)-diones and 4-hydroxyspiro[2-cyclohexene-1,3'-[3H]indol]-2'(1'H)-ones; act as antagonists of mdm2 interactions; useful as potent and selective anticancer agents
05/25/2010US7723367 Amino-tetrazoles analogues and methods of use
05/25/2010US7723363 N-[2-(5-chloro-2-pyridinyl)propyl]-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, used for the control of phytopathogenic fungi of plants; pesticides
05/25/2010US7723362 for controlling acarina
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723359 such as 2-{5-Bromo-2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-4-methyl-1H-benzoimidazole, used in leukocyte recruitment inhibition, modulation of histamine H4 receptors and in treating conditions such as inflammation
05/25/2010US7723358 such as hypertriglyceridaemia, hypercholesterolemia, dyslipidaemia, or obesity; 6-methyl-N-[3-[[1-(methylsulfonyl)-4-piperidinyl]oxy]phenyl]-4'-(trifluoro-methoxy) [1,1'-biphenyl]-2-carboxamide
05/25/2010US7723357 Thalidomide and thalidomide derivatives for treating spinal disorders mediated by nucleus pulposus
05/25/2010US7723349 N-hydroxy-5-methyl-6-{[4-(3-methylphenyl)piperazin-1-yl]carbonyl}-5-azaspiro[2.5]octane-7-carboxamide for example; treating arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723339 signal transduction inhibitor is a PDGF receptor tyrosine kinase inhibitor or an active ingredient which decreases the activity of the epidermal growth factor; antiproliferative agent
05/25/2010US7723333 used in treating and/or preventing cardiovascular disorders, inflammatory diseases, Alzheimer's disease, dyslipidemia and metabolic syndrome
05/25/2010US7723332 Aryl sulfonamides useful for modulation of the progesterone receptor
05/25/2010US7723325 such as [5-(4-cyclopentyl-piperazine-1-carbonyl)-1H-indol-2-yl]-pyrrolidin-1-yl-methanone, useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors
05/25/2010US7723324 Treating anxiety and insomnia; drugs facilitate the inhibitory action of the neurotransmitter GABA; 2-(6-Methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-yl)-1-thiophen-2-yl-ethanone for example
05/25/2010US7723068 Gene cluster involved in safracin biosynthesis and its uses for genetic engineering
05/25/2010CA2593381C Processes for producing 7-isoindolinequinolonecarboxylic acid derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and compositions containing the same as active ingredient
05/25/2010CA2528232C Novel nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
05/25/2010CA2489337C Indole derivatives useful as histamine h3 antagonists
05/25/2010CA2470476C Pyrrolidine and piperidine derivates as nk1 antagonists
05/25/2010CA2457576C Hydrates of optionally substituted 2-(2-pyridinyl)methylthio-1h-benzimidazoles and process for the production thereof
05/25/2010CA2450433C Improved process for preparing benzimidazole-type compounds
05/25/2010CA2321920C 2-(2,6-dioxopiperidin-3-yl)isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines
05/25/2010CA2273917C 3-pyridyl enantiomers and their use as analgesics
05/20/2010WO2010057126A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
05/20/2010WO2010057118A2 Heterocyclic antagonists of prostaglandin d2 receptors
05/20/2010WO2010057104A2 Pyridoindole modulators of nmda receptor and acetylcholinesterase
05/20/2010WO2010057101A2 Compounds useful as hiv blockers
05/20/2010WO2010057088A2 Pyrrolidinyl modulators of nicotinic acetylcholine receptors
05/20/2010WO2010056875A1 Pyridazinones and their use as btk inhibitors
05/20/2010WO2010056865A1 Quinoline derivatives as ion channel modulators
05/20/2010WO2010056720A1 Method for preparing a non-hydratable crystal form
05/20/2010WO2010056656A2 Preparation of crystalline palonosetron hydrochloride
05/20/2010WO2010056633A2 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/20/2010WO2010056588A1 Tetrasubstituted pyridazine hedgehog pathway antagonists
05/20/2010WO2010056585A2 Heteroaryl diamide compounds useful as mmp-13 inhibitors
05/20/2010WO2010056549A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
05/20/2010WO2010056196A1 New compounds 578
05/20/2010WO2010056059A2 Novel crystalline dexlansoprazole and pharmaceutical composition comprising same
05/20/2010WO2010055896A2 Pyridine derivative or its salt, pesticide containing it and process for its production
05/20/2010WO2010055267A1 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof
05/20/2010WO2010055207A1 Chelating, chelating agents and conjugates deriver thereof
05/20/2010WO2010055164A2 Novel inhibitors of flavivirus replication
05/20/2010WO2010055139A1 Process for manufacturing substituted 3-pyridylmethyl ammonium bromides
05/20/2010WO2010055133A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055132A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055131A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055130A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055128A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055127A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055126A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055124A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055117A1 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
05/20/2010WO2010055114A1 Substituted (pyridyl)-azinylamine derivatives as plant protection agents
05/20/2010WO2010055083A1 Novel pyrazolone-derivatives and their use as pd4 inhibitors
05/20/2010WO2010055078A1 Fungicide heterocyclyl-triazinyl-amino derivatives
05/20/2010WO2010055077A1 Substituted (pyridyl)-azinylamine derivatives as fungicides
05/20/2010WO2010055042A1 2-[(1-cyanopropyl)carbamoyl]-5-methoxymethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
05/20/2010WO2010055006A1 Naphthylacetic acids used as crth2 antagonists or partial agonists
05/20/2010WO2010054968A1 Quinazoline derivatives as nk3 receptor antagonists
05/20/2010WO2010054954A1 Process for manufacturing 5-chloromethyl-2,3-pyridine dicarboxylic acid anhydrides
05/20/2010WO2010054952A1 2-[(1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
05/20/2010WO2010027567A3 Tricyclic spirocycle derivatives and methods of use thereof
05/20/2010US20100125143 Process for the preparation of dexlansoprazole
05/20/2010US20100125142 Process for preparing an optically active proton pump inhibitor
05/20/2010US20100125137 Process for preparing Nevirapine
05/20/2010US20100125094 Pyrrolidinyl modulators of nicotinic acetylcholine receptors
05/20/2010US20100125091 Substituted heterocyclic compounds as ion channel modulators
05/20/2010US20100125082 New compounds 578
05/20/2010US20100125080 Compounds for inflammation and immune-related uses
1 ... 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 ... 1080